Constitutive activation of PI3K signalling is associated with hematologic malignancy and is probably triggered by abnormal activations of KIT, FLT3 and RAS, which are frequently muted in AML (20, 21). The gene discussed is PIK3CD; the disease is acute myeloid leukemia.